Scholarly Index
Yi Lin
Mayo Clinic in Arizona; 37,805 total citations; 824 total publications; best world rank #10
Mayo Clinic in Arizona
37,805Total citations
824Total publications
78H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| CAR-T cell therapy research | Lifetime | 148 | US 91 | 99.44 |
| Multiple Myeloma Research and Treatments | Lifetime | 163 | US 87 | 98.94 |
| Biosimilars and Bioanalytical Methods | Lifetime | 108 | US 41 | 97.77 |
| Protein Degradation and Inhibitors | Lifetime | 479 | US 247 | 96.53 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 713 | US 291 | 93.35 |
| Safe Handling of Antineoplastic Drugs | Lifetime | 839 | US 260 | 60.03 |
| CAR-T cell therapy research | 2021-2025 | 10 | US 5 | 99.85 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 41 | US 16 | 99.45 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 20 | US 9 | 98.34 |
| Protein Degradation and Inhibitors | 2021-2025 | 160 | US 76 | 96.37 |
| Integrated Circuits and Semiconductor Failure Analysis | 2021-2025 | 108 | US 37 | 94.13 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 371 | US 171 | 96.62 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 460 | US 203 | 95.41 |
| Viral Infectious Diseases and Gene Expression in Insects | 2021-2025 | 121 | US 31 | 92.42 |
| Biomedical Ethics and Regulation | 2021-2025 | 291 | US 117 | 77.15 |
| Safe Handling of Antineoplastic Drugs | 2021-2025 | 115 | US 23 | 63.51 |